Myriad Genetics Inc: (NSDQ: MYGN)

(U.S: NSDQ) As of Oct 01, 2014 03:59 PM ET

 Add to portfolio

$38.30 USD

-0.27 (-0.70%)

Volume: 500,764

Zacks Rank : 3-Hold [?]     3    

Brokerage Reports

Search for reports:

0 items in cart

MYRIAD GENETICS [MYGN]

Reports for Purchase

Showing records 1 - 20 ( 61 total )

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 1

09/25/2014

Company Report

Pages: 12

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 2

07/09/2014

Company Report

Pages: 12

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 3

04/08/2014

Company Report

Pages: 12

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 4

12/20/2013

Company Report

Pages: 13

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 5

09/19/2013

Company Report

Pages: 13

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 6

08/16/2013

Company Report

Pages: 12

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 7

07/12/2013

Company Report

Pages: 12

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 8

05/10/2013

Company Report

Pages: 11

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 9

04/17/2013

Company Report

Pages: 11

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 10

03/05/2013

Company Report

Pages: 11

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 11

02/12/2013

Company Report

Pages: 11

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 12

12/20/2012

Company Report

Pages: 10

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 13

11/28/2012

Company Report

Pages: 4

Terminating Coverage Due to Analyst Departure.

Provider: Dougherty and Company, LLC.

Price: 10.00

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 14

11/07/2012

Company Report

Pages: 9

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 15

09/18/2012

Company Report

Pages: 8

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 16

09/07/2012

Company Report

Pages: 6

MYGN: CMS Releases Preliminary Payment Methodology Continued Uncertainty for BRACAnalysis Reimbursement Until at Least November, Maintain NEUTRAL

Provider: Dougherty and Company, LLC.

Analyst: HUSAIN J

Price: 25.00

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 17

09/04/2012

Company Report

Pages: 6

MYGN: CMS Releases Preliminary Payment Methodology Continued Uncertainty for BRACAnalysis Reimbursement Until at Least November, Maintain NEUTRAL

Provider: Dougherty and Company, LLC.

Analyst: HUSAIN J

Price: 25.00

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 18

08/17/2012

Company Report

Pages: 9

Price: 24.95

Research Provided by a Third Party

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 19

08/15/2012

Company Report

Pages: 6

MYGN: Drawing a Line in the Sand for FY13 Guidance

Provider: Dougherty and Company, LLC.

Analyst: HUSAIN J

Price: 25.00

Company: MYRIAD GENETICS

Industry: MED-BIOMED/GENE

Record: 20

06/18/2012

Company Report

Pages: 8

MYGN: 2013 Reimbursement Uncertainty for BRACAnalysis Takes Us to the Sidelines Downgrading to NEUTRAL

Provider: Dougherty and Company, LLC.

Price: 25.00

Research Provided by a Third Party